Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · Real-Time Price · USD
60.82
+0.76 (1.27%)
Dec 5, 2025, 4:00 PM EST - Market closed

PBH Revenue

Prestige Consumer Healthcare had revenue of $274.11M in the quarter ending September 30, 2025, a decrease of -3.41%. This brings the company's revenue in the last twelve months to $1.11B, down -0.02% year-over-year. In the fiscal year ending March 31, 2025, Prestige Consumer Healthcare had annual revenue of $1.14B with 1.10% growth.

Revenue (ttm)
$1.11B
Revenue Growth
-0.02%
P/S Ratio
2.71
Revenue / Employee
$1,850,798
Employees
600
Market Cap
2.92B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20251.14B12.41M1.10%
Mar 31, 20241.13B-2.37M-0.21%
Mar 31, 20231.13B40.91M3.76%
Mar 31, 20221.09B143.45M15.21%
Mar 31, 2021943.37M-19.65M-2.04%
Mar 31, 2020963.01M-12.77M-1.31%
Mar 31, 2019975.78M-65.40M-6.28%
Mar 31, 20181.04B159.12M18.04%
Mar 31, 2017882.06M75.81M9.40%
Mar 31, 2016806.25M91.62M12.82%
Mar 31, 2015714.62M117.24M19.63%
Mar 31, 2014597.38M-22.74M-3.67%
Mar 31, 2013620.12M179.03M40.59%
Mar 31, 2012441.09M104.58M31.08%
Mar 31, 2011336.51M43.91M15.01%
Mar 31, 2010292.60M-1.74M-0.59%
Mar 31, 2009294.35M-20.76M-6.59%
Mar 31, 2008315.11M-3.53M-1.11%
Mar 31, 2007318.63M21.97M7.40%
Mar 31, 2006296.67M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings